Systemic lupus erythematosus (SLE)
J. Michelle Kahlenberg, MD, PhD
University of Michigan
Chandra Mohan, MD, PhD
University of Houston
Systemic lupus erythematosus (SLE) is a complex autoimmune disease marked by a great degree of heterogeneity. Alterations in several immune cell subsets have been observed in SLE. This session will cover the key mechanisms that underlie the immune abnormalities in SLE, which can provide crucial insights into the heterogeneity of this disease. Participants will acquire critical knowledge related to the development of novel therapeutic strategies for this disease.